Skip to content

13F-HR filed by BOONE CAPITAL MANAGEMENT LLC

BOONE CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 13 holding rows worth $316,976,542.

Accession
0001214659-23-015115
Filed
2023-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 13 entries on the cover page, a total value of $316,976,542 stated on the cover page (in dollars after the unit check, H1), rows summing to $316,976,542 with VALUE read as dollars as filed, 13F file number 028-23055. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNUM GROUP COM91529Y106Stock867,565$42,675,522dollars as filed
Cigna Corporation125523100COM129,917$37,165,356dollars as filed
MOLINA HEALTHCARE INC60855R100COM113,178$37,109,934dollars as filed
Danaher Corporation235851102COM129,163$32,045,340dollars as filed
ENOVIS CORPORATION194014502COM502,731$26,509,006dollars as filed
Amgen Inc.031162100COM98,126$26,372,344dollars as filed
BIOGEN INC COM09062X103Stock96,115$24,702,516dollars as filed
GLOBUS MED INC CL A379577208Stock428,452$21,272,642dollars as filed
BAXTER INTL INC071813109COM469,405$17,715,345dollars as filed
QUANTERIX CORP74766Q101COMMON STOCK568,544$15,430,284dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock570,682$15,397,000dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM389,791$12,317,396dollars as filed
BRIDGEBIO PHARMA INC10806X102COM313,381$8,263,857dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-23-015115this filing2023-11-14acceptance time not in the bulk data set